SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Discovery " 1,242 found 🔀 AI-powered Shuffle
Federal government to spend $5B on AI-powered health, infrastructure research
More than 15 federal agencies will use AI to investigate the root causes of chronic diseases, develop treatments for pediatric cancer, expedite the discovery of prescription drugs and enhance U.S. energy infrastructure, among other related…
Emory receives U.S. Genesis Mission award to speed discovery through AI
Emory physicists will lead a team using AI to advance understanding of the fluid dynamics of plasma — from the lab to the cosmos — through the Department of Energy’s Genesis Mission.
5 projects at UW–Madison aimed at transforming science and energy with AI receive DOE Genesis Mission funding
The projects, spanning fusion to critical minerals, are among 278 funded awards to national labs, companies, universities and non-profits in order to accelerate breakthroughs in energy, scientific discovery and national security through a new platform that combines AI, supercomputing, quantum systems and advanced scientific instruments.
USDA NIFA NEXTGEN Animal Science Discovery Program Expands National Reach in Third Summer
New Sustainable Urban Agriculture track, expanded student cohort and growing institutional partnerships highlight the USDA-funded initiative preparing the next generation of agriculture professionals. The USDA NIFA NEXTGEN Animal Science Discovery Program (ANSCId) concluded its third summer on July 10 with a closing ceremony at the Douglass Student Center, Trayes Hall, on the Rutgers–New Brunswick campus. […]
Department of Energy's New AI-for-Science ‘Genesis Mission’ Awards Funding to 5 UT Research Projects
Five UT teams have been awarded funding from the DOE’s Genesis Mission, an initiative working to harness artificial intelligence for advances in energy dominance, discovery science and national security.
Carnegie Mellon's AI Science Foundry Selected by NSF To Help Build National Infrastructure for AI-Enabled Scientific Discovery
Carnegie Mellon University's AI Science Foundry, one of the world's most advanced AI-powered research facilities, has been selected as a node in the U.S. National Science Foundation's (NSF) Programmable Cloud Laboratory (PCL) Testbed, a national initiative to build a network of AI-enabled laboratories.
Wyss Institute receives Massachusetts Life Science Center award to advance metabolomics and lipidomics research across Massachusetts ecosystem
By Benjamin Boettner (BOSTON) — The Wyss Institute at Harvard University has received an award from the Massachusetts Life Science Center (MLSC), enabling it to host a next-generation metabolomics and lipidomics analytical platform. The platform will allow its researchers to creatively pursue new approaches to biomarker and drug discovery across multiple health challenges the Institute...
US to spend $5 billion on health, construction research powered by AI
Agencies will use the funding to identify the root causes of chronic diseases, accelerate drug discovery, develop longer-lasting building materials.
Advancing the next era of national science
OpenAI outlines its commitment to advancing American science working with the U.S. Department of Energy and national labs to use frontier AI to accelerate discovery.
Powering America's Genesis Mission: Microsoft's commitment to scientific discovery
Today, we’re excited to share a long-term commitment to the Department of Energy’s (DOE) Genesis Mission, backed by a $60 million investment designed to accelerate AI for science and the breakthroughs it can deliver for the country. This deepened commitment includes Microsoft’s new Scientific Partnership Advancing Research & Knowledge coordination hub and program office, otherwise...
DOE Unveils First Genesis Mission Awards for AI-Driven Science
Nearly 300 projects selected from historic RFA response spanning all 50 states to accelerate breakthroughs in energy, discovery science, and national security. WASHINGTON, July 22, 2026 — The U.S. Department of Energy (DOE) today announced the first projects selected under the Genesis Mission Request for Applications (RFA). The national portfolio of research teams will help develop […]
Fresno Discovery Center bringing science for students and families
The Fresno Discovery Center is where science comes to life for students and families.
'Double Helix’ artwork illuminates the beauty of science in motion
Near the main entrance of The University of Texas at San Antonio’s Health Science Center campus, a striking metallic “Double Helix” sculpture greets thousands of drivers each day as they make their way through the South Texas Medical Center — a metropolis of discovery, education, research and innovation. Rising skyward, the angled aluminum sculpture […]
Researchers gather at Cornell Tech to explore AI for molecular science
Researchers from around the world gathered at Cornell Tech for a workshop exploring how physics-aware artificial intelligence can accelerate the discovery of molecules and materials while improving the reliability of machine learning models.
Freedom, trust and the future of science: Nobel laureates reflect on the ideas shaping tomorrow
Behind every scientific discovery are years, sometimes decades, of fundamental research, failed experiments, uncertain funding, international collaboration and the freedom to pursue questions without knowing where they might lead. The Nobel laureates recently gathered at the 75th Lindau Nobel Laureate Meeting in Germany argued that scientific breakthroughs depend on far more than brilliant ideas alone. Those conversations unfolded against the backdrop of Russia’s full-scale war against Ukraine, ongoing conflicts in the Middle East and growing geopolitical competition. The question running through the discussions was therefore broader than science itself: what conditions make discovery possible? ‘Europe is a space of freedom’
NY Attorney Letitia James praises federal judge’s ruling to pause entertainment industry merger
A FEDERAL JUDGE’S restraining order on Monday halts an $81 million Paramount/Warner Brothers Discovery merger.
Where science meets the shoreline, Iowa Lakeside Laboratory builds for the future
Construction is underway on a new Innovation and Discovery Lab at Iowa Lakeside Laboratory that will expand hands-on learning for students of all ages. The new space will also support research to better understand and protect the water quality of the Iowa Great Lakes.
New grant to improve discovery of potential diagnostic, therapeutic molecules
Carly Schissel, assistant professor of chemistry, is part of a multi-institution team that has been selected to receive funding from the Scialog: Automating Chemical Laboratories initiative. The initiative supports teams of early-career scientists doing fundamental science to accelerate advances in laboratory technologies using automation and artificial intelligence.
AEW CEO Tony Khan: The Paramount deal for Warner Bros. Discovery would be great for my wrestling business
Why Tony Khan says this mega media merger would be a "huge opportunity" for AEW.
Science that spans borders
Argonne welcomes three Japanese students through the U.S.-Japan MEXT pilot program, which builds the next generation of the STEM workforce through international partnership and mentorship, expands discovery and fosters collaboration.
Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin
The pharmaceutical company has demonstrated how AI can transform how drugs discovery and is now scaling AI across R&D to accelerate the discovery of next-generation medicines.
Scientists have found an ancient sea worm with jaws made from a mysterious 'bio-metal' never encountered before, a discovery that could rewrite what we know about nature
Imagine you’re playing “20 Questions” and you start with the classic opener: “Animal, vegetable, or mineral?” Most of the time, a sea worm would be an easy answer: animal. But one particular marine species, the ancient and still-living bristle worm Perinereis cultrifera, complicates that simple choice.
Sharks, sutures & science
From learning how to do surgical sutures on a silicone mat to exploring the anatomy of sharks, frogs and other animals, students are diving into hands-on wildlife science this summer during the Clinic for the Rehabilitation of Wildlife's Conservation Summer Camp. With various camps designed for students in kindergarten through 12th grade, CROW's annual camp combines wildlife conservation, veterinary medicine and outdoor discovery through
Best Entertainment Stocks To Follow Now
Verizon Communications, Walt Disney, Warner Bros. Discovery, Autodesk, SEA, Take-Two Interactive Software, and FOX are the seven Entertainment stocks to watch today, according to MarketBeat's stock screener tool. Entertainment stocks are shares of companies involved in creating, distributing, or mo
Scientists just discovered a lost branch of Australia’s marsupials
Fossils from Queensland suggest a newly recognized marsupial order may have survived in Australia for around 35 million years, rewriting part of the story of how the continent's unique mammals evolved. The discovery challenges the idea that Australia's marsupials all came from a single straightforward ancestral lineage.
Promising Entertainment Stocks To Watch Today
Verizon Communications, Walt Disney, Warner Bros. Discovery, Autodesk, and SEA are the five Entertainment stocks to watch today, according to MarketBeat's stock screener tool. Entertainment stocks are shares of companies that create, produce, distribute, or monetize leisure and media experiences, s
UT San Antonio academic health center ranked among nation’s best for entrepreneurial readiness
UT Health San Antonio, The University of Texas at San Antonio’s academic health center, has been recognized as one of the nation’s top 10 institutions for entrepreneurial readiness, ranking No. 7 in the inaugural Cure Innovation Index for how effectively it helps researchers translate scientific discovery into real-world impact through biomedical innovation and commercialization. […]
As AI spending surges, return-on-investment questions mount
The rapid expansion of artificial intelligence is creating major opportunities while also exposing companies to significant financial risks, The New York Times reports. Larry Ellison and his son are using Oracle-generated wealth to expand into media, with control of Paramount and a potential takeover bid for Warner Bros. Discovery. Meanwhile, Oracle is facing financial pressure […]
Scientists Discover a Planet With the Most Earth-like Conditions Yet
The discovery boosts the chances of finding extraterrestrial life.
Harvard scientists detect atmosphere on distant ‘Earth-like’ planet
The first-of-its-kind discovery is expected to set off a search for signs of life.
Science for the final mile: Researchers gather to shape the future of polio eradication
For more than half a century, scientific discovery has helped protect millions of children from one of the world's most feared diseases. Today, as the world
Scientists finally solved how a common gut bacterium triggers colon cancer
Researchers solved a long-standing mystery behind how a bacterial toxin associated with colorectal cancer damages the colon. The toxin first binds to a receptor called claudin-4, giving it access to attack the cells' protective barrier. After identifying this weak point, the team designed a decoy protein that successfully blocked the toxin in mice. The discovery could pave the way for new therapies to prevent inflammation and colon tumors.
The States Try to Topple WarnerMount…Thus Begins the Local Antitrust Era
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Well, it looks like it’s time for another strategy column. Can I finally avoid writing about M&A? No, it seems I cannot. Admittedly, I’m a week early with this column, since I usually put it out every other week. But this news couldn’t wait. This will make three “Most Important Stories” in a row with a merger or acquisition as its centerpiece. First, Roku-Fox (an acquisition), then Comcast-NBCUniversal (a divestment!), and now the State AGs and the WGA’s lawsuits against Paramount’s pursuit of Warner Bros. Discovery (antitrust). M&A is usually the “most important” topic any given week, simply because a giant company merging or breaking up (or preventing those outcomes) can have the biggest impact on the streaming board. If you think about these companies as players in a game, changing the number of players is one of the biggest changes you can make. I shouldn’t really complain, either, since this lawsuit is very good news for customers and suppliers (econ speak for talent, workers and indie studios in Hollywood). So let me answer some questions about this potential trial, along with (shudder) making some heavily caveated predictions. I’ll also look at whether Hollywood must consolidate, whether or not the states can win, trouble at X-Box, Netflix’s YouTube binge, and more. Plus, I have five images that visualize this merger and the harm, including three brand new data looks you’ve never seen before. Subscribe Most Important Story of the Week - Can The States and the WGA Stop Hollywood’s Consolidation (Crisis)? If every other newsletter and news outlet is writing about the same story, I try to avoid writing about it as well, but I can’t ignore a story this consequential. The story of the last year was the fate of Warner Bros. Discovery, and this development potentially extends that saga into 2027. As I tried to figure out my angle, I realized, like my last column, I’m again faced with a series of questions. These questions, though, are much more forward-looking. Will the states win? Will the WGA win? If so, what happens to Warner Bros. Discovery? Either way, will this chill the market for future mergers? So you know what that means: predictions. About the future, no less, the hardest thing to predict.1 Just remember: nothing here comes with a guarantee. And the more confident someone is in their predictions, the less you should trust them. This situation is incredibly fluid, nuanced, uncertain and tenuous. So let’s try to explain what may happen. Question: Why File this Lawsuit? I’ll admit, a few months back, I was fairly pessimistic about the fate of this lawsuit. Rumors had started bubbling up that the state Attorneys General (in particular California) wanted to settle with either some minor divestments (usually CNN) or behavioral remedies. And that tracked for me: the states usually settle lawsuits, like the recent John Deere right-to-repair suit. Yet, they plan to fight this. (As they did the LiveNation-Ticketmaster monopolization trial and the Nexstar-Tegna merger.) Honestly, that also makes a ton of sense. Frankly, this move is just good politics for these State AGs. Most are still running for higher and higher office in blue states—some folks have emphasized that only Democratic AGs joined this suit, but given the Ellison/Trump ties, and fears of retribution, that tracks—and a high profile case like this will help them move up the electoral ladder, especially since Paramount and its leadership (the Ellisons, father and heir) have sided with the other side of the political aisle. That makes them unsympathetic to Democratic voters and Hollywood workers in particular. Why did this lawsuit happen? In addition to the very real concerns about industry consolidation, this is why. That said, I don’t think we would have seen this lawsuit for Netflix and Warner Bros., simply because they’re more sympathetic and aligned with Democrats. But those consolidation concerns are real. The “town”—meaning Hollywood and such—really is seeing the damage of mergers on this industry. That’s why the WGA also filed its own lawsuit in defense of workers as well. (Wildcard: What about Europe? Will they try to stop the deal, too? There have been some rumors out of the UK they may try to fight the deal, and UK enforcers just stopped a Getty Images-Shutterstock tie up, so there is precedence. This argument could go either way, though. On one hand, the EU doesn’t need to step in, cause they states are handling it. On the other hand, this could make the EU’s case easier. Just imagine if both sides coordinated. I’ll simply say, “We’ll see!”) Question: Will The State AGs or the WGA Win? Can the state AGs play David to Paramount-Skydance’s Goliath here? That’s really the whole thing, isn’t it? If you know this result, you could make a lot of money. When things are uncertain, it’s tempting to shrug and say, “Eh” meaning it’s a 50/50 proposition. I wouldn’t, though. When in doubt, you should expect that the merging parties succeed. AT&T did successfully buy Warner Bros., after all, and Disney bought Fox without any challenges. Many judges are extremely sympathetic to mergers, and I’d bet the state AGs get a judge who will allow the merger. (Even Obama-appointed judges often allow mergers.) As I understand it, we’ll see two main attacks. First, theatrical films. The AGs are arguing that, when it comes to share of box office and the number of both “wide releases” and blockbuster (or “tentpole”) films, the merging parties will have over 27% market share. Now, the Supreme Court once ruled from on high that any merger that exceeds 30% is presumptively illegal, but that’s guidance, not an ironclad bar. Still, the states will have to argue that this is close to having too much power, and with that power, this will likely further worsen the theater/studio splits in particular. Indeed, as Matthew Stoller pointed out, “just five studios are responsible for 95% of all blockbusters; if this merger goes through, then Paramount and Disney will control 60% of that.” So yes, movie studios will be very concentrated after this merger. Want me to visualize some of that? Well, here’s the share of films that grossed over $200 million at the domestic box office since 2022. (Note: this isn’t all films released in over 3,000 screens, but it is a good look at market power.) First, here are the 43 films by studio: Notice all the blue (Disney), orange (Universal), and purple (Warner Bros)? Yeah, those studios are powerful, and this combines Paramount with one of them. Here’s the look by studio and share of the films that grossed over $200 million: Now, if you look at that and also think, “Huh, should we break up Disney?” I’m with you. I’ve seen some folks poo-poo this idea that this is a real category, but it is! For an upcoming article, I’ve been pulling data on the share of top 100 films at the box office as a share of total box office, and it’s massive. Here’s the chart: (This analysis looks at The-Number’s top 100 films and total domestic box office each year.) To be clear, tentpoles make up 80.7% of the box office each year, so I do think it’s a genuine market. (To be clear, films grossing over $50 million make up 80% of the domestic box office, and films grossing over $100 million make up 64.1%.) I mean, the top 100 films at the box office make up 95% of each year’s grosses. Worse, the combined studios will likely cut output to flex that market power. Everyone can just look at what happened to Disney and Fox to see the precedent. (With fewer films, the remaining theaters have to give more for those few films that remain.) Here’s an image I’ve used a lot, the share of wide-release films from Disney and Fox over time: The AGs will also argue that this consolidation will also impact the cable industry. In this case, the consolidation is actually worse, but that environment is…complicated. Paramount will argue that the cable industry is shrinking. That said, predictions that cable will “go to zero” also don’t look very well supported by the data, as the declines are shrinking, meaning “cable” or “vMVPDs” will likely stabilize at some point. Can the state Attorneys General win on those two main arguments? I honestly don’t know. Again, I’d bet no, since history in general supports that, but it depends on the judge/jury and how they interpret the arguments. Notably, Paramount won’t face accusations about monopoly power in other areas, like streaming, news, sports rights, or vertical integration. I tend to disagree with leaving out sports rights, but I also see the appeal for a simpler case. The states also aren’t really pushing novel theories about labor harm either, which should help. (By the way, Sean McNulty at The Ankler wrote a great run through of potential options, and Capitol Forum also wrote a great paper on theatrical consolidation. Both these pieces predated the lawsuit. Matthew Stoller is also out with his analysis of the pros and cons of the case too.) In some ways, the WGA’s case is even stronger. Quoting Sean McNulty’s summary: “The WGA is citing WARNAMOUNT as crossing a 30% market share in multiple sectors, a number that the Supreme Court has precedent for deeming “presumptively anticompetitive” in a market. According to the WGA numbers, WARNAMOUNT would have represented: - 35% of film writing jobs between 2021 and 2024 - 36% of TV writing projects between 2022 and 2025 - 38% of overall deals between 2021 and 2024” Notably, antitrust enforcers did win recently in the Penguin-Simon & Schuster merger by focusing on labor impact, so don’t count this thinking out. (Wildcard: Will the states try to get a jury trial? Most likely no, they’ll let a judge handle it. If I’m them, though, I’d try to put this in front of a jury. Juries tend to understand monopoly power in a more realistic way than judges faced with legions of economists.) Question: What if They Win? What if They Lose?
Essential Strategies for New Science Facilities
First-time lab developers succeed not by intentionally building flexible, partnership-driven discovery ecosystems.
New Jersey Couple Aids Meteorite Discovery After it Crashes Through Their Roof
A New Jersey couple helped scientists uncover the makeup of an unusual asteroid after it fell into their bedroom.
Astronomers Detect the First True Sugar in Interstellar Space
The discovery hints that life’s ingredients may form before planets exist.
Paramount-WBD merger could impact entertainment options
California Attorney General Rob Bonta joins "Here's the Scoop" to discuss how the merger between Paramount Skydance and Warner Bros. Discovery could impact the entertainment industry.
Wall of Entertainment Taps Chronicle Media to Power Audience Discovery and Growth for Its First U.S. Series
SAN FRANCISCO & LONDON, July 14, 2026--How do you find the exact viewers a new show is built for and turn them into a loyal, growing audience? That question is at the heart of a new multi-series partnership announced today between UK digital entertainment studio Wall of Entertainment and audience simulation platform Chronicle Media.
Wall of Entertainment Taps Chronicle Media to Power Audience Discovery and Growth for Its First U.S. Series
How do you find the exact viewers a new show is built for and turn them into a loyal, growing audience? That question is at the heart of a new multi-series p...
Google Images gets a Pinterest-like redesign focused on discovery
Now, when users navigate to Google Images, they'll see a "For You" gallery of images tailored to their interests and browsing history.
OpenAI’s IPO Conundrum | AI & Business for July 14
Plus, Apple’s legal sparring, and Wall Street’s problem with AI drug discovery.
Johns Hopkins APL’s Yee and Murchie Honored for Lasting Impact in Space Science | Johns Hopkins University Applied Physics Laboratory
Scientists Sam Yee and Scott Murchie were jointly awarded APL’s Lifetime Publication Achievement Award for work that has documented discovery, driven space missions, shaped scientific priorities, and advanced the field.
This dinosaur fossil captures the final moments of a T. rex attack
A fossilized Edmontosaurus skull with a Tyrannosaurus tooth still embedded in its face has given scientists rare evidence of a dramatic predator-prey encounter. The discovery suggests the giant carnivore delivered an incredibly powerful face-to-face bite, offering new clues about how Tyrannosaurus hunted.
A Sweet Surprise: Scientists Find Sugar Deep in Our Galaxy
It’s the first time a sugar molecule has been detected in interstellar space. The discovery provides tantalizing new clues into how life may have arisen on Earth.
Body found near business in Folsom under investigation
(FOX40.COM) — The Folsom Police Department is investigating the discovery of a body that was found near a business early Monday morning. FPD said officers and detectives responded to reports of a b…
Integrating AI as a Human-Guided Tool in Translational Science
Peter Tummino of Nimbus Therapeutics explains how drug discovery and development experts can apply AI across targeted workflows with intention and creativity.
Light Can Act as a Quantum Brake to Slow Movement in The Nanoworld, Scientists Discover
"This discovery of light-induced quantum friction fundamentally changes our understanding... "
Supporting Science Is An Act Of Patriotism
As America turns 250, a look at why curiosity, evidence and discovery have always been at the heart of the American experiment.
At Family Science Night, Wonder Comes Before Answers.
BAR HARBOR—Family Science Night isn’t really about science. It’s about wonder. It’s about watching a five-year-old realize that the tiny creature under a microscope is a real living thing. It’s about a teenager discovering that the scientist explaining genetics or regeneration isn’t much older than they are. It’s about parents seeing curiosity spread across a child’s face the way excitement spreads across a crowd at a Fourth of July parade. For one evening, families realize that the laboratory isn’t some secretive place where knowledge is hidden behind white coats and closed doors. They learn that the lab is a place their neighbors work, their friends’ parents work, and it becomes a place where questions matter more than answers. It’s a place where wonder is the origin for knowledge. At the lab, children learn that it’s okay not to know. Adults remember that they once asked “Why?” about everything. Scientists are reminded why they fell in love with discovery in the first place. There are experiments, games, obstacle courses, and demonstrations, of course. But those are really just invitations—to touch, to explore, to laugh, to make mistakes, and to ask one more question. In a world that often rewards certainty, Family Science Night celebrates curiosity. And perhaps that’s its greatest gift. Long after the microscopes are packed away and the experiments are over, what families take home isn’t just a few new facts about biology. They take home the feeling that discovery belongs to everyone—that science isn’t something happening somewhere else by someone else. It’s simply what happens when people are given permission to wonder. A Family Science Night at the Mount Desert Island Biological Laboratory is one of those rare community events where children and adults can experience science as something they do, not just something they read about. Hands on discovery allows hands-on learning and joy. Real scientists, some local, some scientist-interns (but still scientists) just in college make science real, approachable, and exciting. And there, complex ideas like forever chemical-filtration, DNA and so much more become not complex. Instead, they become fun. Summer fellows are challenged to explain cutting-edge biomedical research in ways a first-grader—and their grandparent—can understand. Past activities have explored gene expression, kidney function, axolotl regeneration, worms, microplastics, and phytoplankton through games and creative demonstrations. Though it’s called family night, you can also see adults going from station to station, exploring, learning together across ages. Family Science Night reflects the laboratory’s broader mission of breaking down barriers between researchers and the public, helping people understand how scientific discoveries relate to everyday life and the health of Maine’s environment. Family Science Night transforms a world-class research laboratory into a giant interactive classroom, where curiosity is encouraged, questions are celebrated, and families discover that science isn’t just something that happens in a lab—it’s an adventure anyone can join. About MDI Biological Laboratory For more than 125 years, MDI Bio Lab has been a center for training and research in comparative biology. In the last two decades its biomedical research has focused on aging, regeneration, and environmental toxins. The Laboratory houses 11 research groups staffed by an international team of world-class scientists and graduate students. It also leads a statewide network of colleges, universities and research institutions that collaborate to provide training, research experiences and financial support to help young Mainers play a bigger role in today’s biomedical revolution. Located on Maine’s rugged coast, the Laboratory’s 100+ acre campus houses research facilities, cottages and dorms that house visiting scientists and students. It is also home to MDI Bioscience, a subsidiary working to design innovative techniques to speed the drug discovery process. LINKS TO LEARN MORE NIH INBRE MDI BIOLOGICAL LABORATORY Photos: Carrie Jones and Shaun Farrar/Bar Harbor Story HELP SUPPORT THE BAR HARBOR STORY When we started The Bar Harbor Story, we didn’t know if anyone would read it. But you showed up. You shared. You sent tips. Now—over 400,000 views every month later—it’s clear: people here care about their community and each other. We’ve kept everything free because news should never be out of reach, but every one of our stories takes time to write, and your support keeps The Bar Harbor Story going. If you value our work, please consider a paid subscription, a founding membership, or a sponsorship. It truly helps us cover one more meeting, tell one more story, shine one more light. Even $5 a month makes a difference. Click here to become a one-time supporter now. Thank you so much for being here. Founding member information can be found here. Have questions about sponsorships? Just send Shaun an email at sfarrar86@gmail.com, he’d love to hear from you. Subscribe Share Bar Harbor Story Share Leave a comment
Astronomers discover unexplained spin pattern in early galaxies - Futura-Sciences
A consistent pattern in the deep universe Lior Shamir, an associate professor of computer science at Kansas State University, analyzed images of 263 early galaxies captured through the JWST Advanced Deep Extragalactic Survey. Shamir used quantitative shape analysis to determine the rotation of each galaxy. The data revealed that roughly...
Entertainment Stocks To Watch Today
Verizon Communications, Walt Disney, SEA, Take-Two Interactive Software, Roblox, Warner Bros. Discovery, and TKO Group are the seven Entertainment stocks to watch today, according to MarketBeat's stock screener tool. Entertainment stocks are shares of publicly traded companies that make money from
Experimental drug reverses severe fatty liver disease by repairing the gut
An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could open the door to a new class of treatments for MASH and potentially other diseases tied to gut health.
Nobel-Winning U.S. Chemist Omar Yaghi Will Move to China to Lead A.I. Institute
Omar Yaghi of the University of California, Berkeley, will head an initiative to apply artificial intelligence to the discovery of new materials.
A vitamin A discovery is changing what scientists know about vision
A surprising discovery is reshaping scientists' understanding of how humans develop sharp central vision before birth. Instead of blue cone cells migrating away from the retina's center, the study found they transform into red and green cones under the influence of vitamin A-related signals and thyroid hormones. The findings could improve lab-grown retinal tissue and lay the groundwork for future cell therapies to restore vision lost to age-related eye diseases.
AI helped scientists discover two new superconductors, bringing them closer to a room-temperature breakthrough that could change electronics
Artificial intelligence is now fast becoming an important component in scientific investigations, and its recent achievement may have very significant effects on the advancement of technology. Scientists devised a way to utilise artificial intelligence in scientific research, which has not only resulted in the discovery of two new superconductors, but has also expedited the process of discovering even more superconductors.
Scientists finally crack nature's secret for building better cancer drugs
Researchers have cracked the code behind bacteria's ability to naturally manufacture multiple versions of powerful anti-cancer drugs. The discovery could make it much easier to engineer new cancer treatments inspired by nature, including improved versions of existing medicines.
INCUBASE Studio Accelerates Collectible Entertainment with GochaGocha's 23-Location Asia Debut of a New Photo Card Experience
INCUBASE Studio is expanding its IP entertainment ecosystem with the launch of GochaGocha, a new smart photo card machine platform developed by subsidiary INCUTix. Following a rapid rollout across 23 locations in Hong Kong, Taipei, Kuala Lumpur and Bangkok in early June, GochaGocha introduces a new channel connecting fans with officially licensed content through discovery, collectability and convenience.
Fermilab marks 70 years of neutrino science and leads next-generation experiment
As Fermilab commemorates 70 years since the discovery of the neutrino at the Savannah River Site in the United States, the lab also celebrates its multiple generations of pioneering neutrino research. Today, Fermilab is building the next era of neutrino discovery through the development of the world-leading Deep Underground Neutrino Experiment.
Schrödinger’s anthill: Quantum entanglement found in a crystal large enough to hold
A centimeter-sized crystal has revealed clear signs of quantum entanglement, showing that large, everyday objects can display surprisingly deep quantum behavior. The discovery could help solve the mystery of strange metals while opening new possibilities for ultra-precise quantum sensors and other advanced technologies.
KUOW’s new podcast Pocket Science digs into the groundbreaking research happening right here in the Pacific Northwest
Today KUOW launches Pocket Science, a podcast that takes you up close to the scientific research and discovery happening all around the region and introduces you to the scientists in the thick of it.
IFT: Proposed US federal grant rules threaten nutrition science funding & competitiveness
The US Office of Management and Budget (OMB) recently proposed rules to rewrite the Uniform Guidance — the rulebook for all federal grants. Institute of Food Technologists (IFT) chief science and technology officer tells Nutrition Insight that these rules are set to undermine the nation’s scientific research for food and nutrition and hinder global competitiveness.
Farewell, atom-smashing Large Hadron Collider
After 18 years of discovery, it's goodbye LHC and hello High-Luminosity Large Hadron Collider.
Baton Rouge residents engage with art and science during Free First Sunday event
BATON ROUGE — The Louisiana Art and Science Museum invited residents to a day full of exploration, creativity and discovery during Free First Sunday.
Scientists Found An Enormous Structure In Space That Shouldn't Exist
The discovery of a second enormous structure has raised fresh questions about the cosmological principle.
31 alien-like marine species discovered off the coast of Brazil
A ghostly squid, speedy gossamer worm, and more dwell 600 to 3,300 feet beneath the waves.
A hidden weakness in deadly cancers could lead to powerful new treatments
A UCLA study has identified a hidden Achilles' heel in aggressive small cell cancers that have resisted new treatments for decades. Scientists found that tumors lacking the RB gene become critically dependent on the protein E2F3 for survival. Blocking E2F3 shut down tumor growth in laboratory models, and existing FDA-approved drugs may be able to exploit this vulnerability. The discovery could pave the way for faster development of more effective therapies.
This toad exists only in Canada—and scientists have finally discovered why
Scientists have identified something that may be even more uniquely Canadian than the beaver or moose: a genetically distinct western toad population found only in Canada. The discovery, made by researchers from the University of Ottawa, points to a rare and previously unrecognized group of toads living in the Canadian Rockies and raises fresh questions about conservation, biodiversity, and how much wildlife still remains to be fully understood.
The New Anthropic Tool That Could Change How Drugs Are Developed
Introducing Claude Science, the AI platform designed to expedite the discovery of promising new therapies. Anthropic will also use it in-house to pursue innovative treatments for 'neglected' diseases.
Fort Rickey closed on July 3rd because of the Heat
Fort Rickey Discovery Zoo closed their doors to the public on July 3rd because of the extreme heat.
New PamStealer macOS malware uses clever tradecraft to remain stealthy
The discovery underscores the increased effort being poured into Mac infostealers.
Stem cell scientists engineer 'synthetic organizer' cells to improve kidney organoids
In a study published in Science, USC researchers paired a biological discovery with an engineering feat to create more faithful, reproducible lab-grown kidney structures from stem cells, known as organoids.
Scientists Sound the Alarm: Antarctic Discovery Is More Disturbing Than Anyone Feared - Futura-Sciences
The Frozen Continent Is Changing Faster Than We Thought Antarctica has always been a tough nut to crack for scientists. Its complex and sometimes baffling phenomena have long made it mysterious, and recent findings suggest its influence on our planet’s climate could be much greater than we thought. In September...
A strange LIGO signal could reveal the missing link behind dark matter
An unusual gravitational wave signal has renewed hopes that primordial black holes, long considered purely theoretical, may finally be within reach of discovery. If confirmed, they could solve one of astronomy's greatest mysteries by explaining the nature of dark matter.
Building connections across molecular life science
ASBMB President Ed Eisenstein reflects on how the society shaped his scientific career and outlines his vision for expanding connections across academia, industry and government to accelerate discovery, translation and community-building.
Students Explore Science And Research At Fourth Annual Discovery Day
Local students joined Cincinnati Children’s Discovery Day to explore research labs, meet scientists, and learn about careers in science and medicine.
Anthropic launches Claude Science for pharma researchers
Anthropic had made a big life sciences play with the launch of Claude Science, an AI 'workbench' for researchers involved in drug discovery.
An enormous explosion has occurred in deep space – and scientists caught it within minutes of the detonation | BBC Sky at Night Magazine
Using the Submillimeter Array observatory on Maunakea, Hawaii, astronomers zoomed in on a gamma‑ray burst within minutes of its discovery.
Anthropic Launches Claude Science to Court Pharma Ahead of IPO
Anthropic unveiled Claude Science, an AI workbench designed to run — not just assist with — pharma research. The company is seeking to build out its customer base in the pharma sector as it deepens its healthcare push ahead of a widely anticipated IPO.
Scrolling for science: How a Twitter post discovered a new wasp in Fukuoka, Japan
Researchers at Kyushu University recently identified a wasp species, Eupelmus curvator, in Japan for the first time after citizen scientists posted photos of it on Twitter (now X), marking both a new national record and the first formal description of the male of the species. The discovery highlights the growing role of social media in biodiversity research, allowing scientists to tap into observations from the public that would otherwise go unnoticed.
Anthropic unveils drug discovery plans alongside Claude Science, an AI tool for drugmakers
At an event on Tuesday, the AI heavyweight said it plans to target "neglected" diseases.
Researchers say Anthropic’s Claude Science will boost drug discovery
Anthropic's Claude Science aims to speed up drug discovery. Northeastern scientists weigh in on what it could mean for their research.
Anthropic Launches Claude Science AI Workbench for Scientific Research
June 30, 2026 — AI has the potential to dramatically accelerate the pace of scientific discovery and the development of healthcare interventions. Since launching efforts in the life sciences last fall, […]
Anthropic launches AI drug discovery program, joining tech giants in betting on healthcare
Anthropic will start an internal drug discovery program, part of a new push to sell artificial intelligence tools to drugmakers.
Anthropic launches AI drug discovery program, joining tech giants in betting on healthcare
Anthropic will start an internal drug discovery program, part of a new push to sell artificial intelligence tools to drugmakers.
L’Oréal-UNESCO for Women in Science Week 2026: Celebrating excellence
From 8 to 11 June 2026, UNESCO and the Fondation L’Oréal welcomed the five laureates of the 2026 L’Oréal-UNESCO for Women in Science International Awards to Paris for a week of exchanges, discovery
Scientists find ozone depletion began decades before discovery of ozone hole
Ozone depletion began decades before discovery of ozone hole, MIT scientists have found. Using modern tools, they also determined that carbon tetrachloride, a common dry-cleaning and degreasing agent, was at the root of early ozone loss.
Evidence points to potential new LCD screen for Nintendo Switch 2
The Nintendo Switch 2 screen could be getting a revision, based on the latest evidence. On a Chinese resale site, a listing recently appeared for a a new model of the system’s LCD panel. Sharp would apparently behind the updated screen. The current Nintendo Switch 2 features a panel from Innolux. This new screen has a different circuit, connector, and...
Databricks and Nvidia Launch Genesis Workbench for AI Scientists
AI is becoming an increasingly important tool for drug discovery. However, for many pharmaceutical and biotech companies, the challenge isn’t finding more powerful models. It’s getting existing models to work […]
KATALIN KARIKÓ
She was met with resistance, got demoted and eventually forced to leave academia – but Katalin Karikó never lost focus, doubling-down on her work to harness mRNA for new vaccines and therapies. Karikó’s Nobel Prize-awarded discovery enabled the development of effective vaccines against COVID-19, offering protection to millions of people.
Comcast to split cable business from media through NBCUniversal, Sky spinoff
Comcast will split into two publicly traded companies through a spinoff of NBCUniversal and Sky, separating its cash-generating broadband arm from a media and entertainment business under pressure from streaming rivals and industry consolidation. The latest U.S. media industry shake-up follows years of cord-cutting as legacy players chase scale to better compete with Netflix while Paramount Skydance's $110 billion deal for Warner Bros Discovery is set to boost competition. Comcast, which leans on cable for much of its cash flow, is also losing broadband customers to fixed wireless offerings from T-Mobile and Verizon and to fiber rivals building out networks.
Google Cloud to Offer Specialist AI Models for Science Research
Alphabet Inc.’s Google will start offering specialist artificial intelligence models from software company SandboxAQ through its cloud service, expanding enterprise and research access to technology designed to accelerate drug discovery, materials science and semiconductor manufacturing.
AI scientist company Edison Scientific tapped by team behind Metsera to create new biotechs
Edison Scientific and investment firm Population Health Partners are teaming up to leverage AI agents in drug discovery and development.
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
Scientists discover what triggers belly fat as we age
Aging may trigger the appearance of specialized stem cells that supercharge the body's ability to create new belly fat. The discovery reveals a potential biological driver of middle-age weight gain and a promising target for future anti-obesity treatments.
Raptor discovery in Argentina points to prehistoric links with China
Unearthed on opposite sides of the world, fossils of Kank australis and velociraptors sport matching claws, revealing evolutionary ties.
Scientists Baffled by Discovery of Rare “Pink Floyd” Spider Hidden in Home Walls - Futura-Sciences
The Birth of a “Pink Floyd” Spider Tiny, discreet, and quietly settled on urban walls, a new species of spider was recently discovered in Colombia—and christened as a tribute to the iconic rock band Pink Floyd. As part of a study published in the journal Zoosystematics and Evolution, South American...
Should “Success” in Science Be Measured Differently?
Publication volumes are one of the main ways that success is measured for researchers today. From mentorship to real-world impact, scientists argue that “publish or perish” pressures overlook many of the contributions that drive discovery forward.
Discovery Education Earns Five 2026 CODiE Award Nominations Spanning Math, Science, Digital Citizenship, and Immersive Learning
Discovery Education Earns Five 2026 CODiE Award Nominations Spanning Math, Science, Digital Citizenship, and Immersive Learning
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Microsoft Discovery Aims To Advance The Era Of Agentic Science
The cloud-based agentic AI platform aims to help human researchers overcome resource constraints and complex data challenges to accelerate science at scale.